One limitation of X-ray crystallography and NMR is that the structures they produce don’t always reflect what proteins look like in the cell. Swedish biotech startup Sidec Technologies promises to solve this problem — and contribute to drug discovery — by applying electron microscopy to imaging of proteins in three dimensions. Last week, the Stockholm-based company received a boost for its efforts, announcing additional funding of 10 million krona ($1.3 million) from Industrifonden, the Swedish Industrial Development Fund.